RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-dadb6e54db3ed23eGRADE VERY_LOW
agarikon (fomitopsis officinalis) constituents — cancer
direction NULL · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
LOWnumeric
2bound studies
Bound studies (2 shown of 2)
STU-07df64b028a00961ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-24e194a3c57c25e8IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
Opposition screen
SCREEN · 2 candidates considered · 2 bound as opposing
SYNTHESIS SYN-ebdbc887ec53de — outcome QUALITATIVE_ONLY · UNCERTAIN ×2 · not_assessed_quantitatively · 2 members
PROVENANCE → epmc:38569989, epmc:41050420 · PKG b18261b6ac1569a7…
CLAIM · CLM-ad1d5bbb4631fcceGRADE VERY_LOW
agarikon (fomitopsis officinalis) constituents — glucose
direction NULL · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
LOWnumeric
1bound studies
Bound studies (1 shown of 1)
STU-07df64b028a00961ANIMAL · ANIMAL · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
Opposition screen
SCREEN · 1 candidates considered · 1 bound as opposing
SYNTHESIS SYN-5e74a48ac6120f — outcome SYNTHESIS_INAPPROPRIATE · UNCERTAIN ×1 · not_assessed_quantitatively · 1 members
PROVENANCE → epmc:38569989 · PKG b18261b6ac1569a7…
Bounded preview — representative records only. The full release ships 5 claims and 7 observations.